Nova Cannabis Stock Fundamentals
| NVACFDelisted Stock | USD 1.26 0.00 0.00% |
Nova Cannabis fundamentals help investors to digest information that contributes to Nova Cannabis' financial success or failures. It also enables traders to predict the movement of Nova OTC Stock. The fundamental analysis module provides a way to measure Nova Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nova Cannabis otc stock.
Nova |
Nova Cannabis OTC Stock Return On Equity Analysis
Nova Cannabis' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nova Cannabis Return On Equity | -0.2 |
Most of Nova Cannabis' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nova Cannabis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Nova Cannabis has a Return On Equity of -0.1987. This is 99.17% lower than that of the Healthcare sector and significantly lower than that of the Pharmaceutical Retailers industry. The return on equity for all United States stocks is 35.9% lower than that of the firm.
Nova Cannabis Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nova Cannabis's current stock value. Our valuation model uses many indicators to compare Nova Cannabis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nova Cannabis competition to find correlations between indicators driving Nova Cannabis's intrinsic value. More Info.Nova Cannabis is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nova Cannabis' earnings, one of the primary drivers of an investment's value.Nova Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nova Cannabis' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Nova Cannabis could also be used in its relative valuation, which is a method of valuing Nova Cannabis by comparing valuation metrics of similar companies.Nova Cannabis is currently under evaluation in return on equity category among its peers.
Nova Fundamentals
| Return On Equity | -0.2 | |||
| Return On Asset | -0.0287 | |||
| Profit Margin | (0.05) % | |||
| Operating Margin | (0.03) % | |||
| Current Valuation | 59.13 M | |||
| Shares Outstanding | 57.15 M | |||
| Shares Owned By Insiders | 62.72 % | |||
| Shares Owned By Institutions | 5.20 % | |||
| Price To Book | 0.44 X | |||
| Price To Sales | 0.14 X | |||
| Revenue | 134.36 M | |||
| Gross Profit | 24.89 M | |||
| EBITDA | (7.32 M) | |||
| Net Income | (20.61 M) | |||
| Cash And Equivalents | 6.22 M | |||
| Cash Per Share | 0.11 X | |||
| Total Debt | 60.11 M | |||
| Debt To Equity | 1.11 % | |||
| Current Ratio | 1.07 X | |||
| Book Value Per Share | 0.92 X | |||
| Cash Flow From Operations | (9.98 M) | |||
| Earnings Per Share | (0.30) X | |||
| Number Of Employees | 548 | |||
| Market Capitalization | 35.92 M | |||
| Total Asset | 118.7 M | |||
| Z Score | 1.0 | |||
| Net Asset | 118.7 M |
About Nova Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nova Cannabis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Cannabis based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Nova Cannabis Inc. engages in the operation of retail cannabis stores with a focus on the recreational-use cannabis market in Canada. As of March 31, 2022, the company operated 78 cannabis stores in Alberta, Ontario, and Saskatchewan. Nova Cannabis operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 548 people.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Nova Cannabis information on this page should be used as a complementary analysis to other Nova Cannabis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Nova OTC Stock
If you are still planning to invest in Nova Cannabis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nova Cannabis' history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |